| 2023 | | Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort | 박래웅, 박해심, 이영수 |
| 2023 | | Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease | 박해심, 이영수, 장재혁, 전현섭 |
| 2021 | | Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses | 박래웅, 박해심, 이영수 |
| 2020 | | Lysophosphatidylserine induces eosinophil extracellular trap formation and degranulation: Implications in severe asthma | 박해심, 최영우 |
| 2020 | | Macrophage-derived progranulin promotes allergen-induced airway inflammation | 박해심 |
| 2020 | | Management of Allergic Patients During the COVID-19 Pandemic in Asia | 박해심, 이영수 |
| 2020 | | Metabolic shift favoring C18:0 ceramide accumulation in obese asthma | 김승현, 박해심, 최영우 |
| 2020 | | Metagenome analysis using serum extracellular vesicles identified distinct microbiota in asthmatics | 박해심 |
| 2023 | | Micrococcus luteus-derived extracellular vesicles attenuate neutrophilic asthma by regulating miRNAs in airway epithelial cells | 박해심, 최영우 |
| 2022 | | Mono-n-butyl phthalate regulates nuclear factor erythroid 2–related factor 2 and nuclear factor kappa B pathway in an ovalbumin-induced asthma mouse model | 박해심, 신유섭, 유민숙 |
| 2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
| 2019 | | Neutrophil activation in occupational asthma | 박해심, 이영수 |
| 2019 | | New phenotypes in hypersensitivity reactions to nonsteroidal anti-inflammatory drugs | 박해심, 신유섭, 이영수 |
| 2024 | | New targets for type 2-low asthma | 박해심 |
| 2020 | | Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence | 박해심 |
| 2019 | | Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases | 박해심 |
| 2023 | | Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper | 박해심 |
| 2020 | | Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab | 박해심, 예영민 |
| 2020 | | NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care | 박해심, 우성대 |
| 2021 | | Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma | 박해심, 신유섭, 예영민, 최영우 |
| 2020 | | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea | 박해심, 신유섭, 예영민 |
| 2020 | | Osteopontin contributes to late-onset asthma phenotypes in adult asthma patients | 김승현, 박해심 |
| 2021 | | Persistent eosinophilic inflammation in adult asthmatics with high serum and urine levels of leukotriene E4 | 김승현, 박해심 |
| 2021 | | Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model | 박해심 |
| 2021 | | Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs | 박해심 |
| 2021 | | Potential metabolic biomarkers in adult asthmatics | 박해심, 최영우 |
| 2023 | | Prediction of the number of asthma patients using environmental factors based on deep learning algorithms | 박해심, 장재혁 |
| 2020 | | Pulmonary Surfactants: a New Therapeutic Target in Asthma | 박해심, 장재혁, 최영우 |
| 2022 | | Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities | 박해심 |
| 2024 | | Real-World Effectiveness of Statin Therapy in Adult Asthma | 박래웅, 박해심, 양형모, 이영수, 장재혁 |
| 2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
| 2021 | | Recent update on the management of anaphylaxis | 박해심, 장재혁 |
| 2023 | | Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis | 박해심 |
| 2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence | 박해심, 신유섭, 예영민 |
| 2023 | | Role of club cell 16-kDa secretory protein in asthmatic airways | 박해심 |
| 2022 | | Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma | 김승현, 박해심 |
| 2021 | | S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma | 박해심, 신유섭, 최영우 |
| 2019 | | Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis | 남동호, 박해심, 신유섭, 예영민, 이소희 |
| 2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
| 2022 | | Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients | 박해심, 신유섭, 최영우 |
| 2021 | | Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria | 박해심, 예영민 |
| 2020 | | Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics | 박해심, 예영민 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Specific antibody deficiency in adult patients with igg or igg subclass deficiency | 박해심, 장재혁 |
| 2021 | | Sputum antinuclear antibody serves as a biomarker for severe asthma | 박해심, 신유섭 |
| 2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
| 2021 | | The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma | 박해심, 신유섭 |
| 2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |
| 2023 | | The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate-Exacerbated eosinophilic asthma model | 박해심, 신유섭 |
| 2022 | | The Role of Di(2-Ethylhexyl) Phthalate as an Exacerbating Factor in Chronic Spontaneous Urticaria | 박해심, 신유섭 |
| 2023 | | Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma | 박해심, 신유섭, 유민숙, 최영우 |
| 2020 | | Toward personalization of asthma treatment according to trigger factors | 박해심 |
| 2019 | | Transforming growth factor-beta1 and eosinophil-derived neurotoxins contribute to the development of work-related respiratory symptoms in bakery workers | 박해심, 이소희 |
| 2021 | | Update on latex allergy: New insights into an old problem | 박해심 |
| 2020 | | Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity | 박해심 |
| 2021 | | Urine microbial extracellular vesicles can be potential and novel biomarkers for allergic diseases | 박해심, 최영우 |
| 2020 | | Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 | 박해심 |
